Market revenue in 2022 | USD 362.9 million |
Market revenue in 2030 | USD 793.8 million |
Growth rate | 10.3% (CAGR from 2022 to 2030) |
Largest segment | Artificial organ |
Fastest growing segment | Artificial bionics |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Artificial Organ, Artificial bionics |
Key market players worldwide | Zimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial organs and bionics market will help companies and investors design strategic landscapes.
Artificial organ was the largest segment with a revenue share of 70.6% in 2022. Horizon Databook has segmented the Mexico artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico accounted for the second-largest share in Latin America’s artificial organ and bionics market in 2019. Favorable initiatives undertaken by private & social security sectors, such as the North American Free Trade Agreement (NAFTA), to promote usage of medical equipment and products, are likely to contribute to market growth.
Mexico has been a popular medical tourism destination for the U.S. and Canada, owing to the low cost of treatments available in the country. Moreover, its proximity to the U.S. and lower travel costs are boosting medical tourism in the country, thereby increasing the demand for transplant procedures.
In addition, medical tourism is a major revenue generator for the country, as treatments are 30% to 50% cheaper than those in the U.S. According to the National Transplant Center, around 21,414 people in Mexico were awaiting an organ or tissue transplant in 2017.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico artificial organs and bionics market, including forecasts for subscribers. This country databook contains high-level insights into Mexico artificial organs and bionics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account